Search results
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . [2] She has also been a prominent investor in Shark Tank India investing in over 100 companies.
1M Followers, 1,254 Following, 504 Posts - Namita Thapar (@namitathapar) on Instagram: "ED, Emcure. Shark @ Shark Tank India.
Namita Thapar is one of the sharks on Shark Tank India. The IPO includes fresh issue of equity shares worth ₹ 800 crore and an Offer For Sale (OFS) of 1.14 crore equity shares by promoters and ...
Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around 12.68 lakh shares through the offer for ...
Namita Thapar is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.
6 hours ago · The Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs 960-1,008 apiece. Investors can apply for a minimum of 14 equity shares and its multiples thereafter.
Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.
2 days ago · Namita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on Shark Tank, is set to earn approximately Rs 127 crore through the company's upcoming IPO. The issue ...
1 day ago · Namita Thapar is poised to earn 293 times her initial investment after partially offloading her stake in Emcure Pharmaceuticals, according to the company's red herring prospectus. At the upper end ...
9 hours ago · Emcure Pharmaceuticals initial public offering is set to open for subscription on Wednesday, July, 3, 2024. The IPO comprises a fresh issue of 7.9 million shares totaling Rs 800.00 crores and an offer for sale of 11.4 million shares amounting to Rs 1,152.03 crores. The pharma company raised Rs 582 ...
